The Relationship Between Fibromyalgianess and Clinical Features, Disease Activity in Patients With Systemic Lupus Erythematosus

被引:0
作者
Varman, Busra [1 ]
Parlak, Selman [1 ]
Ecesoy, Hilal [2 ]
机构
[1] Konya Beyhekim Training & Res Hosp, Dept Rheumatol, Konya, Turkiye
[2] Karamanoglu Mehmetbey Univ, Dept Rheumatol, Karaman, Turkiye
关键词
fibromyalgianess; polysymptomatic distress scale; systemic lupus erythematosus; PREVALENCE;
D O I
10.1002/msc.70052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Fibromyalgia (FM) is a chronic syndrome characterised by widespread pain, fatigue, and symptoms such as sleep disturbances, cognitive impairment, and mood disorders. FM prevalence is notably higher among systemic lupus erythematosus (SLE) patients compared with the general population, often leading to diagnostic challenges. Misinterpreting FM as SLE activity can result in overtreatment. This study aimed to evaluate fibromyalgianess and its relationship with the clinical and immunological characteristics of SLE patients using comprehensive scoring methods for better diagnostic accuracy. Materials and Methods: This cross-sectional study included 50 SLE patients meeting the 2019 EULAR/ACR classification criteria. Patients with coexisting autoimmune diseases or severe systemic conditions were excluded. Clinical data, SLEDAI scores, and fibromyalgianess severity were assessed using the Polysymptomatic Distress Scale (PSDS). Patients were categorised into groups based on fibromyalgia diagnostic criteria: widespread pain and SLE-FM. Statistical analysis was performed using SPSS, with p < 0.05 considered significant. Results: Among 50 patients (45 female, 5 male; mean age 42.04 +/- 12.5), 24% had fibromyalgianess, and 18% experienced widespread pain. Female patients exhibited significantly higher PSDS scores (p < 0.05). While NSAID use was associated with increased PSDS scores (p < 0.001), no significant relationship was found between fibromyalgianess and SLEDAI scores or organ involvement. Conclusion: Fibromyalgianess in SLE patients primarily reflects heightened pain sensitivity and symptom severity rather than disease activity. Incorporating fibromyalgianess assessment into routine SLE management may prevent diagnostic and therapeutic pitfalls and improve treatment outcomes. Multidisciplinary approaches, including pharmacological and non-pharmacological strategies, are essential for effective care.
引用
收藏
页数:4
相关论文
共 50 条
[31]   CLINICAL-FEATURES OF PATIENTS WITH MILD SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
YAMANE, K ;
SHOME, GP ;
AKAMA, T ;
SUZUKI, H ;
MATSUI, Y ;
KASHIWAGI, H .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1991, 20 (06) :397-405
[32]   Clinical features of systemic lupus erythematosus patients with splenomegaly: focussed on the cytopenias [J].
Nam, So Hye ;
Park, Han-Seung ;
Ahn, Soo Min ;
Oh, Ji Seon ;
Kim, Yong-Gil ;
Lee, Chang-Keun ;
Yoo, Bin ;
Hong, Seokchan .
INTERNAL MEDICINE JOURNAL, 2023, 53 (12) :2341-2345
[33]   Relationship of Excess Weight with Clinical Activity and Dietary Intake Deficiencies in Systemic Lupus Erythematosus Patients [J].
Meza-Meza, Monica R. ;
Vizmanos-Lamotte, Barbara ;
Francisco Munoz-Valle, Jose ;
Parra-Rojas, Isela ;
Garaulet, Marta ;
Campos-Lopez, Bertha ;
Montoya-Buelna, Margarita ;
Cerpa-Cruz, Sergio ;
Martinez-Lopez, Erika ;
Oregon-Romero, Edith ;
De la Cruz-Mosso, Ulises .
NUTRIENTS, 2019, 11 (11)
[34]   Musculoskeletal features in systemic lupus erythematosus and their relationship with disability [J].
Murphy, NG ;
Koolvisoot, A ;
Schumacher, HR ;
Von Feldt, JM ;
Callegari, PE .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 1998, 4 (05) :238-245
[35]   Relationship between clinical features and binding domains of anti-prothrombin antoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome [J].
Akimoto, T ;
Akama, T ;
Kono, I ;
Sumida, T .
LUPUS, 1999, 8 (09) :761-766
[36]   Ovarian function and disease activity in patients with systemic lupus erythematosus [J].
Shabanova, S. S. ;
Ananieva, L. P. ;
Alekberova, Z. S. ;
Guzov, I. I. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (03) :436-441
[37]   Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices [J].
Fadda, S. ;
Nassar, H. ;
Gamal, S. M. ;
Al-azizi, H. .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2015, 74 (06) :529-532
[38]   Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity [J].
Hassan, Samia Z. ;
Gheita, Tamer A. ;
Kenawy, Sanaa A. ;
Fahim, Atef T. ;
El-Sorougy, Iman M. ;
Abdou, Manal S. .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2011, 14 (04) :325-331
[39]   Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices [J].
Griffiths, B ;
Mosca, M ;
Gordon, C .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (05) :685-708
[40]   Clinical features and independent predictors of interstitial lung disease in systemic lupus erythematosus [J].
Lian, Fan ;
Zhou, Jun ;
Wang, Yu ;
Cui, Wei ;
Chen, Dongying ;
Li, Hao ;
Qiu, Qian ;
Zhan, Zhongping ;
Ye, Yujin ;
Liang, Liuqin ;
Yang, Xiuyan ;
Xu, Hanshi .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02) :4233-4242